Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Do not do concentration math in your head
Key Metrics & Financial Highlights Metric Value Year 1 Revenue $600-800K Year 3 Revenue $10-18M LTV:CAC Ratio 9.8:1 Gross Margin 66% Target Exit Valuation $60-100M (Years 3-4) Initial Capital Required $50-75K MARKET OPPORTUNITY Market Size & Growth Current market: 12 million Americans on GLP-1 medications 2026 projection: 15+ million users Growth rate: 25% annually Patient spend: $900-1,500/month per patient on medication alone Search intent: 50,000+ monthly searches for GLP-1 nutrition solutions Total Addressable Market 12M users 30% willing to pay = 3.6M addressable customers 3.6M $65/month 12 months = $2.8B annual TAM Conservative penetration of 5-10% = $140-280M realistic market Year 1 serviceable market: 1-2% = $28-56M The Problem GLP-1 patients face three critical, interconnected problems: 1
Niche, emerging brands with clear benefits and strong taste profiles are challenging incumbents
Consistent rotation prevents the development of lipodystrophy, a condition where the fat layer at the injection site becomes lumpy or hardened from repeated use, which can affect how the medication absorbs
